Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine as Adjunctive Treatment in Schizophrenia
NCT00097942Phase 2Completed
- Sponsor
- Forest Laboratories
- Start
- Aug 2004
- Primary completion
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in schizophrenia comparing Memantine Arm with Placebo Arm (2 arms). Primary endpoint: Positive and Negative Syndrome Scale - Total. Started Aug 2004; status: completed.
02
Drugs
memantine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00097942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00097942.